Chimpanzee Adenovirus Vaccine Provides Multispecies Protection against Rift Valley Fever
Rift Valley Fever virus (RVFV) causes recurrent outbreaks of acute life-threatening human and livestock illness in Africa and the Arabian Peninsula. No licensed vaccines are currently available for humans and those widely used in livestock have major safety concerns. A ‘One Health’ vaccine developme...
Main Authors: | Warimwe, George M., Gesharisha, Joseph, Carr, B. Veronica, Otieno, Simeon, Otingah, Kennedy, Wright, Danny, Charleston, Bryan, Okoth, Edward, Elena, Lopez-Gil, Lorenzo, Gema, Ayman, El-Behiry, Alharbi, Naif K., Al-dubaib, Musaad A., Brun, Alejandro, Gilbert, Sarah C., Nene, Vishvanath, Hill, Adrian V. S. |
---|---|
Format: | Online |
Language: | English |
Published: |
Nature Publishing Group
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4742904/ |
Similar Items
-
Potency of a thermostabilised chimpanzee adenovirus Rift Valley Fever vaccine in cattle
by: Dulal, Pawan, et al.
Published: (2016) -
Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley Fever vaccine in mice
by: Warimwe, George M, et al.
Published: (2013) -
Chimpanzee Adenovirus Antibodies in Humans, Sub-Saharan Africa
by: Xiang, Zhiquan, et al.
Published: (2006) -
The relative magnitude of transgene-specific adaptive immune responses induced by human and chimpanzee adenovirus vectors differs between laboratory animals and a target species
by: Dicks, Matthew D.J., et al.
Published: (2015) -
Sociocultural and Economic Dimensions of Rift Valley Fever
by: Muga, Geoffrey Otieno, et al.
Published: (2015)